DNTH Stock-Based Compensation

Dianthus Therapeutics Inc · Stock-Based Compensation

DNTH logo

DNTH Stock-Based Compensation

Latest reported$34.27M
DNTH Stock-Based Comp ($662.00K → $34.27M)
High-resolution chart · PNG

DNTH stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dianthus Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
22,793,000
12,894,000
2,900,000
1,518,000
0
0
0
0
2,259,000
662,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.